We are live on ! Find out more
AMYT

Amryt Pharma plc American Depositary Shares
AMYT

Delisted

AMYT was delisted on the 11th of April, 2023.

Back to rankings

64 hedge funds and large institutions have $306M invested in Amryt Pharma plc American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 10

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

4% less funds holding

Funds holding: 67 → 64 (-3)

12% less capital invested

Capital invested by funds: $348M → $306M (-$42.1M)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

Holders
64
Holders Change
-3
Holders Change %
-4.48%
% of All Funds
1.08%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
7
Increased
17
Reduced
10
Closed
10
Calls
$240K
Puts
–
Net Calls
+$240K
Net Calls Change
+$128K

Top Buyers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
+$15.6M
2
NCM
Nantahala Capital Management
Connecticut
+$3.83M
3
HCM
Highbridge Capital Management
New York
+$2.13M
4
ACM
Aquilo Capital Management
California
+$1.77M
5
AC
Armistice Capital
New York
+$1.39M

Top Sellers

Rank Fund Capital Flow
1
Man Group
Man Group
United Kingdom
-$9.93M
2
WA
Whitebox Advisors
Minnesota
-$3.86M
3
WP
Woodline Partners
California
-$1.2M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$510K
5
SCM
Stonepine Capital Management
Oregon
-$311K
Name Holding Trade Value Shares
Change 		Change in
Stake
CF
26
Cantor Fitzgerald
New York
$573K -$156K -20,000 -20%
PA
27
Parallel Advisors
California
$518K – – –
CCM
28
Context Capital Management
California
$506K – – –
Bank of America
29
Bank of America
North Carolina
$473K -$7.99K -1,024 -1%
Legal & General Group
30
Legal & General Group
United Kingdom
$376K +$6.17K +791 +1%
Renaissance Technologies
31
Renaissance Technologies
New York
$328K +$165K +21,100 +82%
BGIM
32
Brandywine Global Investment Management
Pennsylvania
$306K -$50.2K -6,441 -13%
NAM
33
Nexpoint Asset Management
Texas
$280K – – –
Wells Fargo
34
Wells Fargo
California
$235K – – –
TI
35
Trexquant Investment
Connecticut
$222K -$40.1K -5,142 -14%
Geode Capital Management
36
Geode Capital Management
Massachusetts
$208K – – –
NM
37
Newtyn Management
New York
$207K +$231K +29,656 New
HSBC Holdings
38
HSBC Holdings
United Kingdom
$175K – – –
LPL Financial
39
LPL Financial
California
$148K – – –
V
40
Veritable
Delaware
$148K +$165K +21,151 New
VF
41
Virtu Financial
New York
$114K +$127K +16,268 New
GCP
42
GSA Capital Partners
United Kingdom
$90K +$12K +1,543 +14%
Goldman Sachs
43
Goldman Sachs
New York
$79K -$4.16K -533 -5%
BDWM
44
Brewin Dolphin Wealth Management
Ireland
$71K – – –
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$70K +$78.1K +10,013 New
UBS Group
46
UBS Group
Switzerland
$18K +$14.1K +1,806 +238%
AC
47
Armistice Capital
New York
$8.23K +$1.39M +178,000 +18%
BlackRock
48
BlackRock
New York
$8K – – –
JEST
49
JTC Employer Solutions Trustee
Jersey
$8K – – –
RE
50
RBC Europe
United Kingdom
$8K – – –
1
2
3

AMYT Hedge Fund Activity: Q2 2022 in Review

64 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q2 2022, worth a combined $306M — down 12% from $348M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of AMYT and 7 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 17 added.

The largest buyer was UBS O'Connor, opening a new position worth an estimated $15.6M. The largest seller was Man Group, exiting entirely with an estimated $9.93M sold.

  • 64 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q2 2022, down from 67 in Q1 2022.
  • Funds reported $306M of Amryt Pharma plc American Depositary Shares stock for Q2 2022, down 12% quarter-over-quarter.
  • 7 funds opened new Amryt Pharma plc American Depositary Shares positions in Q2 2022 and 10 closed out, a net change of -3 holders.
  • The largest Amryt Pharma plc American Depositary Shares buyer in Q2 2022 was UBS O'Connor, an estimated $15.6M added.
  • The largest Amryt Pharma plc American Depositary Shares seller in Q2 2022 was Man Group, an estimated $9.93M sold.

Based on aggregated 13F filings for Q2 2022.